特朗普政府削减了对生物技术部门的影响,造成失业和阻碍投资。 Trump administration cuts hit biotech sector, causing job losses and discouraging investments.

特朗普政府削减联邦卫生机构经费 加深了生物技术部门的萧条 The Trump administration's cuts to federal health agencies have deepened the biotech sector's slump. 美国食品药品监督管理局的大量裁员和美国国家卫生研究院的资金结增加了中小型生物技术公司的不确定性,影响了药品的批准,并阻碍了投资. Mass firings at the FDA and funding freezes from the NIH increase uncertainty for small and mid-cap biotech firms, impacting drug approvals and discouraging investment. S&P生物技术ETF指数创下18个月的低点, 今年下降20%, The S&P Biotech ETF index hit an 18-month low, down 20% this year, with concerns over the FDA's ability to fulfill its role.